Previous 10 | Next 10 |
Allergan ( AGN -0.4% ) has settled patent infringement litigation with would-be generic competitor Maharashtra, India-based Ajanta Pharma Limited related to hypertension med Bystolic (nebivolol). More news on: Allergan plc, Healthcare stocks news, Read more ...
AbbVie ( ABBV ) is in the process of acquiring Allergan ( AGN ) for a combination of $120.30 in cash and 0.866 shares of ABBV. To date, the deal has secured approvals from China, Brazil, Canada, Ukraine, and Allergan shareholders. The deal does not require a vote of the buyer’s sharehol...
It's been a tough year for AbbVie (NYSE: ABBV) as the stock is closing 2019 not far from where it finished the year before. Question marks about the future of its business have made investors wary of investing in the company. However, given its poor performance in a year that's seen the Hea...
Welcome to the last edition of Insider Weekends for 2019. This has been an interesting year when it comes to insider purchases, with several well-timed purchases by insiders, including: The purchase of Eidos Therapeutics ( EIDX ) by its CEO in June and then again in July . The purchas...
Reuters reports that pharmaceutical companies, including Pfizer (NYSE: PFE ), GlaxoSmithKline (NYSE: GSK ) and Sanofi (NASDAQ: SNY ), are planning to raise prices on more than 200 medicines in the U.S. tomorrow. More news on: Pfizer Inc., GlaxoSmithKline plc, Sanofi, Healthcare stocks ne...
The past year has been great for stocks across the board, but that's made it awfully hard to find reliable dividend-paying stocks that offer satisfactory yields. The average dividend yield for stocks in the S&P 500 index has dwindled to just 1.8% at the moment, but there are stil...
Cowen analyst Steve Scala boosts price target on AbbVie ( ABBV +0.8% ) to $98 from $90, citing the importance of the Allergan's ( AGN +0.4% ) Ubrelvy migraine drug approval. More news on: AbbVie Inc., Allergan plc, Healthcare stocks news, Read more ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). U.S. holiday e-commerce sales grew nearly 19% from the 2018 period, according to new Mastercard data. O...
Purchasers of Allergan's (NYSE: AGN ) Namenda have asked a federal judge to approve a $750M settlement of claims that the drugmaker conspired to keep generic versions of the Alzheimer's medication off the market. More news on: Allergan plc, Healthcare stocks news, Read more ...
Merger activity increased, with nine new deals announced and six deals closing. Deal Statistics New Deals The acquisition of LogMeIn (LOGM) by Francisco Partners for $4.3 billion or $86.05 per share in cash. We added LOGM as a potential deal to the Deals in the Works section on Dece...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...